(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

JERSTRUQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

JERSTRUQ

ST13

US500000090766054

Class

5

Filing

90766054

Registration

6693831

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

11/08/2022

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

06/10/2021

Registration date

04/05/2022

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/05/2022

Last transaction

04/05/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

Brentford, Middlesex, GB

Examiner

BEDNARZ, DUSTIN THOMAS

Law office

N30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Glaxo Group Limited

Representatives

Christopher M. Hanes GlaxoSmithKline

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseasespaininflammationobesity and cognitive disorders; Pharmaceutical preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryoncologicalhepatologicalrespiratoryneurologicalgastrointestinaldermatologicalpsychiatric and immune system related diseases and disorders

Publications

History of USPTO decisions and trademark events.

17 publications found

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/08/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/08/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/08/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/08/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/08/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

04/05/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/18/2022

PUBO

PUBLISHED FOR OPPOSITION

01/18/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/29/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/15/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

12/15/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/15/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

12/15/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/15/2021

DOCK

ASSIGNED TO EXAMINER

12/09/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/31/2021

NWAP

NEW APPLICATION ENTERED

06/14/2021

Continuous trademark protection

Get notified about every new filing that threatens JERSTRUQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.